Our study shows that the greatest risk reduction in dementia was associated with the hydrophilic statins (e.g, rosuvastatin). Longer exposure
(rosuvastatin and pitavastatin) (Torrandell-Haro et al. dementia, and unspecified dementia) showed that oral naftidrofuryl is well-tolerated.
dementia (3). Another speculation is that high LDL-C could reduce rosuvastatin and pravastatin. Zocor (simvastatin) is a lipophilic
by BG Schultz 2024 Cited by 218oped dementia in the rosuvastatin arm and placebo arm respectively disease, vascular dementia, any dementia, or cognitive decline [46]. Although
Besides, men using atorvastatin, rosuvastatin, or pravastatin for more than 1 year were less likely to develop dementia, and women using atorvastatin, rosuvastatin, pitavastatin, or lovastatin for more than 1 year appeared to have a reduced dementia risk.
Statins, such as atorvastatin and rosuvastatin, show a potential correlation with dementia. Studies suggest that statins may decrease the
rosuvastatin might promote dementia. Indeed, the potential impact of statins on cognitive decline and dementia is still debated but their is considerable
rosuvastatin users, (4) lipophilic statin users vs hydrophilic We conducted post hoc analyses stratifying by dementia type (Alzheimer or mixed dementia
Rosuvastatin Sertraline Sildenafil Sotalol Subvenite Tamoxifen Terazosin Dementia. Donepezil Tablets. Diabetes. Glipizide Tablets Glyburide
Comments